3 ms·
For good or bad, any move in this space is going to draw inevitable comparisons to theranos. Yes this current example is based on a proof of concept, but at som
by ineedasername 8y ago
For good or bad, any move in this space is going to draw inevitable comparisons to theranos. Yes this current example is based on a proof of concept, but at some point any research has to hit the product phase, and that is especially when theranos blowback will produce both criticism and scrutiny.
- MBCook 8y agoTheranos is exactly what I thought of as soon as I saw this. They’re not claiming to do it with only a “nano-tainer“ of blood, or to do a bunch of the level sensing things (cholesterol, blood sugar, PSA, etc) that Theranos promised. It’s also not as small as a package of reagents. But it looks like this works the way Theranos CLAIMED their tech worked, only in single use form without the machine to do some of the work for you. Comparisons are 100% inevitable.